Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Self-administered Injectable Drug Therapies and Markets" report has been added to ResearchAndMarkets.com's offering.
Human engineering and user ergonomics play a pivotal role in the design and development of drug self-administration devices, significantly affecting patient safety and compliance. Designers have harnessed powerful tools, such as 3D CAD design software and high-performance materials, over the past decade. However, they increasingly rely on end-user research to define precise design targets for their projects.
Specialty prefilled injection devices, which encompass prefilled pen injectors, autoinjectors, and needle-free injection devices, offer unique opportunities to differentiate products in the era of direct-to-consumer marketing and competition from generics. Features like multi-dose drug cartridges and integrated dose counters enhance ease-of-use for self-administration, fostering brand loyalty among consumers with chronic conditions.
Key Takeaways:
- Human engineering and user ergonomics are critical in the development of drug self-administration devices, impacting patient safety and compliance.
- Designers have adopted advanced tools like 3D CAD design software and high-performance materials.
- End-user research is increasingly vital in defining precise design targets for projects.
- Specialty prefilled injection devices, including pen injectors and autoinjectors, offer opportunities for product differentiation.
- Features like multi-dose drug cartridges and integrated dose counters enhance ease-of-use and foster brand loyalty among consumers with chronic conditions.
Key Topics Covered
1. Executive Summary
2. The Market Opportunity
3. Delivery Market Dynamics
- The Economics of Injectable Drugs
- What's Driving the Growth in Injectable Devices?
- Prefilled Syringes Proliferating
- The Prefilled Syringe Supply Chain
- The Trend toward Self-Administration
- Shifting Demographics
- Innovation in Disposable Device Designs
- Proliferation of Biological Drugs
4. Therapeutic Monoclonal Antibodies
5. Injectable Drug Device Summaries
- Autoinjectors
- Single Fixed Dose
- Variable Dosing
- High Viscosity
- Dual Chamber
6. Wirelessly Enabled Autoinjectors
- Selected Product Specific Autoinjectors
7. Autoinjector Device Design Factors
- Material Selection Issues
- Part Counts and Device Cost
- Safety Features
- Needle Insertion Depth
- Failsafe Activation
- Dose Inspection/Injection Confirmation
- Market Factors
- Lyophilized Drugs/Reconstitution
- Human Engineering/Ergonomics
8. Pen Injectors
- Pen Injector Design Selection Factors
- Standardized Pen Platforms
- Custom Pen Designs
- Reusable Pens
- Dual Chamber Pens
9. Commercial Pen Products
- Hormones
- Enzymes
- Insulins
- Detailed Profiles of 23 Devices
10. Wearable Devices - Analysis and Assessments
- Libertas (Becton Dickinson)
- SmartDose (West Pharmaceuticals)
- Neulasta OnPro Injector (Insulet/Amgen)
- YpsoDose (Ypsomed)
- Electronic Semi-disposable
- eLVD Patch Pump (Elcam)
11. Emerging Technology
- Wireless Data
12. Injectable Drug Market Analysis and Forecasts
- Autoimmune Diseases
- Rheumatoid Arthritis
- Psoriasis
- Multiple Sclerosis
- Hematopoietics
- Hormones
- Osteoporosis
- Fertility
13. Market Factors
- Regulatory Issues
- Device Branding
- Patient Adherence and Ease of Use
- Healthcare Economics
14. Company Profiles
- Becton Dickinson
- West Pharmaceuticals
- Insulet/Amgen
- Ypsomed
- Elcam
For more information about this report visit https://www.researchandmarkets.com/r/vmgft7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
